These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. Improving microvascular outcomes in patients with diabetes through management of hypertension. McGill JB Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966 [TBL] [Abstract][Full Text] [Related]
66. New approaches in the intensive management of cardiovascular risk in the metabolic syndrome. Rosenson RS Curr Probl Cardiol; 2005 May; 30(5):241-79. PubMed ID: 15829899 [TBL] [Abstract][Full Text] [Related]
68. New drugs 2002, part III. Hussar DA Nursing; 2002 Jul; 32(7):55-62; quiz 62-4. PubMed ID: 12352871 [No Abstract] [Full Text] [Related]
69. [Current pharmacological agents. 7. Therapeutic agents used for the treatment of hyperlipemia and hyperuricemia (gout)]. Ando Y Kango Gijutsu; 1986 Jul; 32(9):1176-7. PubMed ID: 3637394 [No Abstract] [Full Text] [Related]
70. Post-transplantation osteoporosis. Stein E; Ebeling P; Shane E Endocrinol Metab Clin North Am; 2007 Dec; 36(4):937-63; viii. PubMed ID: 17983930 [TBL] [Abstract][Full Text] [Related]
71. [Antihypertensive therapy in early stages of chronic kidney disease. Second and third stages of chronic kidney disease]. Gorostidi M; Marín R; Nefrologia; 2004; 24 Suppl(6):91-100, 187-235. PubMed ID: 15696900 [No Abstract] [Full Text] [Related]
72. Randomized clinical trials: prescriptions to be applied with caution! Alderman MH Am J Hypertens; 2008 May; 21(5):483-4. PubMed ID: 18437132 [No Abstract] [Full Text] [Related]
73. New onset diabetes during antihypertensive therapy. Alderman MH Am J Hypertens; 2008 May; 21(5):493-9. PubMed ID: 18437139 [TBL] [Abstract][Full Text] [Related]
74. Long-term medical complications of heart transplantation: information for the primary care physician. Yamani MH; Starling RC Cleve Clin J Med; 2000 Sep; 67(9):673-80. PubMed ID: 10992625 [TBL] [Abstract][Full Text] [Related]
75. Multifactorial approach and adherence to prescribed oral medications in patients with type 2 diabetes. Mateo JF; Gil-Guillén VF; Mateo E; Orozco D; Carbayo JA; Merino J Int J Clin Pract; 2006 Apr; 60(4):422-8. PubMed ID: 16620354 [TBL] [Abstract][Full Text] [Related]
76. The heart of the matter--treating the depressed cardiac patient. J Psychosoc Nurs Ment Health Serv; 1998 May; 36(5):12. PubMed ID: 9604835 [No Abstract] [Full Text] [Related]
77. Drugs on the horizon. De Haen P N Y State J Med; 1972 Aug; 72(15):1969-73. PubMed ID: 4506215 [No Abstract] [Full Text] [Related]
78. Does lipid-lowering therapy slow progression of chronic kidney disease? Wheeler DC Am J Kidney Dis; 2004 Nov; 44(5):917-20. PubMed ID: 15492960 [No Abstract] [Full Text] [Related]
79. Predicting the occurrence of diabetes mellitus in recipients of heart transplants. Krentz AJ Diabet Med; 2000 Jun; 17(6):488. PubMed ID: 10975222 [No Abstract] [Full Text] [Related]
80. Obtaining optimal compliance with drug therapy. Cramer JA Manag Care; 2003 Oct; 12(10 Suppl):9-11; discussion 23-5. PubMed ID: 14606251 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]